Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey

Molecular Pain

Volumn 4, Issue , 2008, Pages

  Jeong, Hyo Jin ^a   Chenu, David ^a   Johnson, Emma E ^a   Connor, Mark ^a   Vaughan, Christopher W ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; 3 [4 (3 CHLOROPHENYL) 1 PIPERAZINYL] 1,1 DIPHENYL 2 PROPANOL; 4 AMINOBUTYRIC ACID 1A RECEPTOR; 4 AMINOBUTYRIC ACID 1B RECEPTOR; 4 AMINOBUTYRIC ACID 1D RECEPTOR; 4 AMINOBUTYRIC ACID 1F RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; FLUOXETINE; N (3 DIMETHYLAMINO 2,3,4,9 TETRAHYDRO 1H CARBAZOL 6 YL) 4 FLUOROBENZAMIDE; N [4 [5 [3 (2 AMINOETHYL) 1H INDOL 5 YL] 1,2,4 OXADIAZOL 3 YL]BENZYL]METHANESULFONAMIDE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; SEROTONIN; SUMATRIPTAN SUCCINATE; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID; GLUTAMIC ACID; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN AGONIST; SUMATRIPTAN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; GABAERGIC TRANSMISSION; IC 50; IN VITRO STUDY; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; MESENCEPHALON; MIGRAINE; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SYNAPTIC TRANSMISSION; ANIMAL; DRUG EFFECT; PHYSIOLOGY;

ANIMALS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MESENCEPHALON; PERIAQUEDUCTAL GRAY; RATS; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT1D; SEROTONIN AGONISTS; SUMATRIPTAN; SYNAPTIC TRANSMISSION;

EID: 57149125441     PISSN: 17448069     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-8069-4-54     Document Type: Article

References (57)

1. Goadsby PJ Lipton RB Ferrari MD Migraine - current understanding and treatment N Engl J Med 2002, 346:257-270 10.1056/NEJMra010917 11807151
2. Humphrey PPA Feniuk W Perren MJ Beresford IJ Skingle M Whalley ET Serotonin and migraine Ann N Y Acad Sci 1990, 600:587-598 10.1111/ j.1749-6632.1990.tb16912.x 2252337
3. Tepper SJ Rapoport AM Sheftell FD Mechanisms of action of the 5-HT1B/ (1D) receptor agonists Arch Neurol 2002, 59:1084-1088 10.1001/ archneur.59.7.1084 12117355
4. Nozaki K Boccalini P Moskowitz MA Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space Neuroscience 1992, 49:669-680 10.1016/ 0306-4522(92)90235-T 1501769
5. Strassman AM Mineta Y Vos BP Distribution of fos-like immunoreactivity in the medullary and upper cervical dorsal horn produced by stimulation of dural blood vessels in the rat J Neurosci 1994, 14:3725-3735 8207485
6. Kaube H Keay KA Hoskin KL Bandler R Goadsby PJ Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat Brain Res 1993, 629:95-102 10.1016/0006-8993(93)90486-7 8287282
7. Goadsby PJ Hoskin KL Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)(1B/D) receptor agonist zolmitriptan (311C90): Are brain stem sites therapeutic target in migraine? Pain 1996, 67:355-359 10.1016/0304-3959(96)03118-1 8951929
8. Storer RJ Goadsby PJ Microiontophoretic application of serotonin (5HT)1B/ 1D agonists inhibits trigeminal cell firing in the cat Brain 1997, 120:2171-2177 10.1093/brain/120.12.2171 9448572
9. Nozaki K Moskowitz MA Boccalini P CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges Br J Pharmacol 1992, 106:409-415 1907519 1327382
10. Cumberbatch MJ Hill RG Hargreaves RJ The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats Eur J Pharmacol 1998, 362:43-46 10.1016/ S0014-2999(98)00764-X 9865528
11. Donaldson C Boers PM Hoskin KL Zagami AS Lambert GA The role of 5-HT1B and 5-HT1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons Neuropharmacology 2002, 42:374-385 10.1016/ S0028-3908(01)00190-3 11897116
12. Potrebic S Ahn AH Skinner K Fields HL Basbaum AI Peptidergic nociceptors of both trigeminal and dorsal root ganglia express serotonin 1D receptors: Implications for the selective antimigraine action of triptans J Neurosci 2003, 23:10988-10997 14645495
13. Jennings EA Ryan RM Christie MJ Effects of sumatriptan on rat medullary dorsal horn neurons Pain 2004, 111:30-37 10.1016/j.pain.2004.05.018 15327806
14. Raskin NH Hosobuchi Y Lamb S Headache may arise from perturbation of brain Headache 1987, 27:416-420 10.1111/j.1526-4610.1987.hed2708416.x 3667258
15. Weiller C May A Limmroth V Jüptner M Kaube H Schayck RV Coenen HH Diener HC Brain stem activation in spontaneous human migraine attacks Nature Med 1995, 1:658-660 10.1038/nm0795-658 7585147
16. Veloso F Kumar K Toth C Headache secondary to deep brain stimulation Headache 1998, 38:507-515 10.1046/j.1526-4610.1998.3807507.x 15613166
17. Welch KM Nagesh V Aurora SK Gelman N Periaqueductal gray matter dysfunction in migraine: Cause or the burden of illness? Headache 2001, 41:629-637 10.1046/j.1526-4610.2001.041007629.x 11554950
18. Keay KA Bandler R Parallel circuits mediating distinct emotional coping reactions to different types of stress Neurosci Biobehav Rev 2001 25 669 678 10.1016/S0149-7634(01)00049-5 11801292
19. Fields HL Basbaum AI Heinricher MM Central nervous system mechanisms of pain modulation Textbook of Pain Philadelphia: Elsevier, Churchill Livingstone McMahon SB, Koltzenburg M 5 2006:125-142
20. Clements JR Beitz AJ Fletcher TF Mullett MA Immunocytochemical localization of serotonin in the rat periaqueductal gray: A quantitative light and electron microscopic study J Comp Neurol 1985, 236:60-70 10.1002/cne.902360106 4056091
21. Bruinvels AT Palacios JM Hoyer D Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain Naunyn Schmiedebergs Arch Pharmacol 1993, 347:569-582 10.1007/BF00166939 8361548
22. Pompeiano M Palacios JM Mengod G Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: Correlation with receptor binding J Neurosci 1992, 12:440-453 1531498
23. 3H]sumatriptan binding sites (5-HT1B, 5-HT1D and 5-HT1F receptors) in human brain: Focus on brainstem and spinal cord Neuropharmacology 1997, 36:535-542 10.1016/S0028-3908(97)00061-0 9225278
24. Bonaventure P Voorn P Luyten WH Jurzak M Schotte A Leysen JE Detailed mapping of serotonin 5-HT1B and 5-HT1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: Clues for function Neuroscience 1998, 82:469-484 10.1016/S0306-4522(97)00302-3 9466454
25. Bruinvels AT Landwehrmeyer B Gustafson EL Durkin MM Mengod G Branchek TA Hoyer D Palacios JM Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain Neuropharmacology 1994, 33:367-386 10.1016/0028-3908(94)90067-1 7984275
26. Strassman A Mason P Moskowitz M Maciewicz R Response of brainstem trigeminal neurons to electrical stimulation of the dura Brain Res 1986, 379:242-250 10.1016/0006-8993(86)90777-8 3742223
27. Bartsch T Knight YE Goadsby PJ Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception Ann Neurol 2004, 56:371-381 10.1002/ana.20193 15349864
28. Knight YE Goadsby PJ The periaqueductal grey matter modulates trigeminovascular input: A role in migraine? Neuroscience 2001, 106:793-800 10.1016/S0306-4522(01)00303-7 11682164
29. Kishimoto K Koyama S Akaike N Synergistic mu-opioid and 5-HT1A presynaptic inhibition of GABA release in rat periaqueductal gray neurons Neuropharmacology 2001, 41:529-538 10.1016/S0028-3908(01)00100-9 11587707
30. Vaughan CW Connor M Bagley EE Christie MJ Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro Mol Pharmacol 2000, 57:288-295 10648638
31. Travagli RA Williams JT Endogenous monoamines inhibit glutamate transmission in the spinal trigeminal nucleus of the guinea-pig J Physiol (Lond) 1996, 491:177-185 1158768 9011609
32. Drew GM Mitchell VA Vaughan CW Glutamate Spillover Modulates GABAergic Synaptic Transmission in the Rat Midbrain Periaqueductal Grey via Metabotropic Glutamate Receptors and Endocannabinoid Signaling J Neurosci 2008, 28:808-815 10.1523/JNEUROSCI.4876-07.2008 18216189
33. Vaughan CW Christie MJ Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro J Physiol (Lond) 1997, 498:463-472 1159215 9032693
34. Matsuoka T Hasuo H Akasu T 5-Hydroxytryptamine 1B receptors mediate presynaptic inhibition of monosynaptic IPSC in the rat dorsolateral septal nucleus Neurosci Res 2004, 48:229-238 10.1016/ j.neures.2003.11.004 15154669
35. Lemos JC Pan YZ Ma XH Lamy C Akanwa AC Beck SG Selective 5-HT1B receptor inhibition of glutamatergic and GABAergic synaptic activity in the rat dorsal and median raphe Eur J Neurosci 2006, 24:3415-3430 10.1111/ j.1460-9568.2006.05222.x 17229091
36. Ho SSN Chow BKC Yung WH Serotonin increases the excitability of the hypothalamic paraventricular nucleus magnocellular neurons Eur J Neurosci 2007, 25:2991-3000 10.1111/j.1460-9568.2007.05547.x 17561813
37. Johnson SW Mercuri NB North RA 5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons J Neurosci 1992, 12:2000-2006 1578282
38. Shen KZ Johnson SW 5-HT inhibits synaptic transmission in rat subthalamic nucleus neurons in vitro Neuroscience 2008, 151:1029-1033 2279230 18248912 10.1016/j.neuroscience.2007.12.001
39. Cameron DL Williams JT Cocaine inhibits GABA release in the VTA through endogenous 5-HT J Neurosci 1994, 14:6763-6767 7965077
40. Stanford IM Lacey MG Differential actions of serotonin, mediated by 5-HT1B and 5-HT2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro J Neurosci 1996, 16:7566-7573 8922413
41. Hopwood SE Stamford JA Multiple 5-HT1 autoreceptor subtypes govern serotonin release in dorsal and median raphe nuclei Neuropharmacology 2001, 40:508-519 10.1016/S0028-3908(00)00192-1 11249960
42. Pullar IA Boot JR Broadmore RJ Eyre TA Cooper J Sanger GJ Wedley S Mitchell SN The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig Eur J Pharmacol 2004, 493:85-93 10.1016/ j.ejphar.2004.04.029 15189767
43. Riad N Garcia S Watkins KC Jodoin N Doucet E Langlois X El Mestikawy S Hamon M Descarries L Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain J Comp Neurol 2000, 417:181-194 10.1002/ (SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A 10660896
44. Chalmers DT Watson SJ Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain-a combined in situ hybridisation/in vitro receptor autoradiographic study Brain Res 1991, 561:51-60 10.1016/0006-8993(91)90748-K 1797349
45. Jeong HJ Han SH Min BI Cho YW 5-HT1A receptor-mediated activation of G-protein-gated inwardly rectifying K+ current in rat periaqueductal gray neurons Neuropharmacology 2001, 41:175-185 10.1016/ S0028-3908(01)00062-4 11489454
46. Boess FG Martin IL Molecular biology of 5-HT receptors Neuropharmacology 1994, 33:275-317 10.1016/0028-3908(94)90059-0 7984267
47. Best AR Regehr WG Serotonin Evokes Endocannabinoid Release and Retrogradely Suppresses Excitatory Synapses J Neurosci 2008, 28:6508-6515 10.1523/JNEUROSCI.0678-08.2008 18562622
48. Chieng B Christie MJ Hyperpolarization by opioids acting on μ-receptors of a sub-population of rat periaqueductal gray neurones in vitro Br J Pharmacol 1994, 113:121-128 1510059 7812601
49. Osborne PB Vaughan CW Wilson HI Christie MJ Opioid inhibition of rat periaqueductal grey neurones with identified projections to rostral ventromedial medulla in vitro J Physiol (Lond) 1996, 490:383-389 1158677 8821137
50. Chiou LC Huang LYM Mechanism underlying increased neuronal activity in the rat ventrolateral periaqueductal grey by a mu-opioid J Physiol (Lond) 1999, 518:551-559 2269434 10381599 10.1111/ j.1469-7793.1999.0551p.x
51. Keay KA Bandler R Vascular head pain selectively activates ventrolateral periaqueductal gray in the cat Neurosci Lett 1998, 245:58-60 10.1016/ S0304-3940(98)00168-2 9596355
52. Hoskin KL Bulmer DCE Lasalandra M Jonkman A Goadsby PJ Fos expression in the midbrain periaqueductal grey after trigeminovascular stimulation J Anat 2001, 198:29-35 1468188 11215764 10.1046/j.1469-7580.2001.19810029.x
53. Bingham S Davey PT Sammons M Raval P Overend P Parsons AA Inhibition of inflammation-induced thermal hypersensitivity by sumatriptan through activation of 5-HT1B/1D receptors Exp Neurol 2001. 167:65-73 10.1006/ exnr.2000.7521 11161594
54. Kayser V Aubel B Hamon M Bourgoin S The antimigraine 5-HT1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain Br J Pharmacol 2002, 137:1287-1297 1573605 12466238 10.1038/sj.bjp.0704979
55. Cumberbatch MJ Hill RG Hargreaves RJ Differential effects of the 5HT(1B/ 1D) receptor agonist naratriptan on trigeminal versus spinal nociceptive responses Cephalalgia 1998, 18:659-663 10.1046/ j.1468-2982.1998.1810659.x 9950621
56. Kaube H Hoskin KL Goadsby PJ Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption Br J Pharmacol 1993, 109:788-792 2175651 8395298
57. Goadsby PJ Can we develop neurally acting drugs for the treatment of migraine? Nature Rev Drug Discovery 2005, 4:741-750 10.1038/nrd1822